| Literature DB >> 35215584 |
Hau Seung Jeremy Wong1,2, Kesaven Bhubalan3,4, Al-Ashraf Abdullah Amirul1,2.
Abstract
Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (P(3HB-co-3HV)) is the most studied short-chain-length polyhydroxyalkanoates (PHA) with high application importance in various fields. The domination of high-cost propionate and valerate over other 3-hydroxyvalerate (3HV) precursors owing to their wide preference among PHA-producing bacteria has hindered the development of diverse production processes. As alkyl alcohols are mainly produced from inexpensive starting materials through oxo synthesis, they contribute a cost-effective advantage over propionate and valerate. Moreover, alkyl alcohols can be biosynthesized from natural substrates and organic wastes. Despite their great potential, their toxicity to most PHA-producing bacteria has been the major drawback for their wide implementation as 3HV precursors for decades. Although the standard PHA-producing bacteria Cupriavidus necator showed promising alcohol tolerance, the 3HV yield was discouraging. Continuous discovery of alkyl alcohols-utilizing PHA-producing bacteria has enabled broader choices in 3HV precursor selection for diverse P(3HB-co-3HV) production processes with higher economic feasibility. Besides continuous effort in searching for promising wild-type strains, genetic engineering to construct promising recombinant strains based on the understanding of the mechanisms involved in alkyl alcohols toxicity and tolerance is an alternative approach. However, more studies are required for techno-economic assessment to analyze the economic performance of alkyl alcohol-based production compared to that of organic acids.Entities:
Keywords: 1-pentanol; 1-propanol; 3-hydroxyvalerate precursor; alkyl alcohol tolerance; biosynthesis; oxo synthesis; poly(3-hydroxybutyrate-co-3-hydroxyvalerate); polyhydroxyalkanoates; propionic acid; valeric acid
Year: 2022 PMID: 35215584 PMCID: PMC8876610 DOI: 10.3390/polym14040670
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Microbial PHA granule, P(3HB-co-3HV) structure, and applications.
Properties improvement after the incorporation of a secondary (and tertiary) component into P(3HB-co-3HV) and their potential applications.
| Incorporated Components A | Changes in the Properties | Potential | Ref. |
|---|---|---|---|
| Packaging | [ | ||
| Therapeutic | [ | ||
| Packaging | [ | ||
| Packaging | [ | ||
| Antimicrobial | [ | ||
| Bone | [ | ||
| Packaging | [ | ||
| Mulch | [ | ||
| Drug | [ | ||
| Bone | [ | ||
| Packaging | [ | ||
| Packaging | [ | ||
| Packaging | [ | ||
| Packaging | [ | ||
| Packaging | [ | ||
| Biomedical, | [ | ||
| Drug | [ | ||
| Skin | [ | ||
| Electrical | [ | ||
| Packaging | [ | ||
| Packaging | [ | ||
| Mulch | [ | ||
| Active food | [ | ||
| Bone | [ |
A Synthetic atactic poly(3-hydroxybutyrate) (α-P(3HB)), bovine serum albumin capped silver (Ag/BSA), ascorbic acid (AS), cellulose nanocrystals (CNC), carbon nanotubes (CNT), dicumyl peroxide (DCP), distillers’ dried grains with solubles (DDGS), hydroxyapatite (HA), organophilic attapulgite (MAT), Miscanthus (Misc), 2-methyl-4-chlorophenoxyacetic acid (MCPA), monomethoxy poly(ethylene glycol) (mPEG), natural rubber (NR), poly(ε-caprolactone) (PCL), poly(d,l-lactide) (PDLLA), poly(butylene succinate) (PBS), poly(butylene adipate-co-terephthalate) (PBAT), poly(ethylene glycol) (PEG), poly(2-hydroxyl ethyl methacrylate) (PHEMA), poly(lactic acid) (PLA), poly(propylene carbonate) (PPC), not available (NA). B Melt-mixed compress molded P(3HB-co-3 mol%3HV):P(3HB-co-18 mol%3HV):ZnO (70:24:6) (PHBVs-D), electrospun P(3HB-co-18 mol%3HV):ZnO (50:50) (PHBVs-P), P(3HB-co-18 mol%3HV):ZnO (50:50) coating on compressed molded P(3HB-co-3 mol%3HV) (PHBVs-C).
Figure 2Schematic bioconversion pathway of organic acids and alkyl alcohols into 3HV [14,57,58,59,60].
P(3HB-co-3HV) production by bacteria from various 3HV precursors.
| Microorganisms and | Biomass | PHA Content | 3HV Composition | 3HV Yield | Ref. | ||
|---|---|---|---|---|---|---|---|
| (wt%) | (g/L) | (mol%) | (g/L) | ||||
| Organic acids | |||||||
| 3.9 | 72 | 2.8 | - | - | - | [ | |
| 2.9 | 21 | 0.6 | 41 | 0.2 | 0.25 | [ | |
| 4.5 | 57 | 2.6 | 25 | 0.7 | 0.16 | [ | |
| 65.9 | 88 | 58 | 36 | 20.8 | 0.11 | [ | |
| 8.2 | 73 | 6.0 | 23 | 1.4 | 0.35 | [ | |
| 112.3 | 57 | 64.0 | 14 | 15.7 | - | [ | |
| 4.2 | 40 | 1.7 | 34 | 0.6 | 0.30 | [ | |
| Activated sludge mixed culture | - | - | - | 31–66 | - | - | [ |
| 8.1 | 72 | 5.8 | 15 | 0.9 | 0.46 | [ | |
| 5.2 | 43 | 2.2 | 17 | 0.4 | 0.42 | [ | |
| 5.3 | 64 | 3.4 | 31 | 1.1 | 0.26 | [ | |
| 7.2 | 40 | 2.9 | 62 | 1.8 | 0.45 | [ | |
| 4.8 | 34 | 1.6 | 47 | 0.3 | 0.14 | [ | |
| 2.5 | 50 | 1.3 | 10 | 0.1 | 0.25 | [ | |
| 5.9 | 62 | 3.7 | 87 | 3.2 | 0.25 | [ | |
| 8.6 | 84 | 7.2 | 28 | 2.0 | 0.50 | [ | |
| 7.3 | 48 | 3.5 | 16 | 0.6 | 0.16 | [ | |
| 4.5 | 49 | 2.2 | 45 | 1.0 | 1.00 | [ | |
| Conjugate bases of organic acids | |||||||
| 1.6–4.1 | 42–67 | 0.8–2.1 | 10–13 | 0.1–0.2 | 0.16–0.49 | [ | |
| 1.5 | 30 | 0.5 | 39 | 0.2 | 0.45 | [ | |
| Sodium salts of organic acids | |||||||
| 5.0 | 32 | 1.6 | 6 | 0.1 | 0.01 | [ | |
| - | 31 | - | 28 | - | - | [ | |
| 0.3–0.7 | 12–56 | Trace | 0–45 | Trace | - | [ | |
| 3.0 | 30 | 0.9 | 12 | 0.1 | 0.02 | [ | |
| 2.4 | 37 | 0.9 | 14 | 0.1 | 0.25 | [ | |
| 4.1–6.1 | 64–89 | 2.1–5.4 | 3–14 | 0.1–0.9 | 0.03–0.17 | [ | |
| 4.2 | 52 | 2.2 | 6 | 0.1 | 0.13 | [ | |
| - | - | 0.3 | - | 0.2 | 0.20 | [ | |
| Alkyl alcohols | |||||||
| 14.7 | 80 | 11.7 | 9 | 1.1 | 0.14 | [ | |
| 5.4 | 50 | 2.7 | 6 | 0.2 | 0.07 | [ | |
| 5.1 | 40 | 2.1 | 8 | 0.2 | 0.22 | [ | |
| 5.4 | 69 | 3.7 | 7 | 0.3 | 0.33 | [ | |
| - | 76 | - | 10 | - | - | [ | |
| 4.8 | 62 | 3.0 | 20 | 0.6 | 0.43 | [ | |
| - | - | 5.0 | 7 | 0.4 | 0.40 | [ | |
| 25–40 | 30–45 | 7.5–18.0 | 14–50 | 2.5–4.5 | - | [ | |
| - | - | 0.3 | - | 0.2 | 0.17 | [ | |
| - | 49–98 | - | 2–51 | - | - | [ | |
| 6.8 | 18 | 1.2 | 100 | 1.2 | - | [ | |
| Mixed precursors | |||||||
| 1.0 | 33 | 0.3 | 73 | 0.2 | 0.24 | [ | |
| 0.5 | 19 | 0.1 | 78 | Trace | - | [ | |
| 6.6 | 67 | 4.4 | 55 | 2.4 | 0.43 | [ | |
Only the most promising condition was included for studies involving multiple cultivation conditions. Trace (concentration < 0.1 g/L). A C. glutamicum ATCC13869 transformant harboring C. necator phaCABRe genes. B C. malaysiensis USMAA2-4 transformant harboring C. necator H16 lipAB genes. C C. necator mutant with P(3HB)-negative phenotype [92]. D H. seropedicae Z69 with the 2-methylcitrate synthase (PrpC) gene eliminated.
Figure 3Techno-economic analysis on PHA production annual costs using pure carbon sources and wastes [93,95].
Figure 4Oxo synthesis of alkyl alcohols [62,97,99].
Figure 5Biosynthesis of 1-propanol by wild-type Propionibacteria through the Wood–Werkman pathway [103,104].
Figure 6Biosynthesis of 1-propanol by wild-type C. propionicumable and C. neopropionicumable through the acrylate pathway [109,110].
Figure 7Biosynthesis of 1-propanol and 1-pentanol by wild-type C. ragsdalei through the carboxylate reduction pathway [112].
Figure 8Biosynthesis of 1-propanol by genetically engineered E. coli BW25113 through co-expression of the citramalate and threonine pathway [115].
Figure 9Biosynthesis of 1-pentanol by genetically engineered E. coli BW25113 through interactive elongation cycles of 2-letoacids [116]. Dash arrow indicates lower selectivity toward the reaction.
Figure 10Biosynthesis of 1-propanol by genetically engineered E. coli BW25113 with activated SBM operon for extended dissimilation of succinate [118].
Figure 11Biosynthesis of 1-pentanol by genetically engineered E. coli BL21(DE3 with acquired carboxylate reduction pathway [119].
Figure 12Timeline of the emergence of alkyl alcohol-tolerant P(3HB-co-3HV)-producing bacteria.